SUBSCRIBE

Breaking News on Supplements & Nutrition - North AmericaEU edition

Cancer risk reduction

News headlines

ENSA: Soy-breast cancer study not reflective of ‘state of scientific knowledge’

The soy industry has hit back at a recent study that suggested soy supplementation could worsen rather than ameliorate breast cancer by influencing gene behaviour.

Curcumin takes center stage, suppliers say

Sales of curcumin supplements are soaring. This perpetually almost-ready-for-prime-time ingredient has finally arrived, suppliers say.

Swiss player ready for reduced cost resveratrol launch

10-year-old Swiss biotech firm Evolva has completed the resveratrol manufacturing cost-reduction programme it embarked on for the antioxidant nearly two years ago when it bought defunct Fluxome’s business for €550,000.

Huge 40-year, 180,000 woman cohort shows flavanols can reduce ovarian cancer risk

Regular consumption of flavanols and flavanone bioactive compounds, found in tea, citrus fruits and fruit juices, can lower the risk of ovarian cancer by as much as 21%, according to a cohort study involving nearly 180,000 women and begun in 1976.

More vitamin D in UK foods than previously: Study

The UK should update vitamin D food and supplement content estimations that have the knock-on effect of distorting population intake levels of the sunshine vitamin by about 3%, a study has concluded.

FTC's fines on weight loss claims total more than all other categories combined, CRN database shows

The Council for Responsible Nutrition has launched a new tool for members that puts together in one place data on recent enforcement actions by the Federal Trade Commission regardling claims made in advertising. The resource can help them avoid making the same mistakes, said Steve Mister, president and CEO of CRN.

Deal cements supply relationship for more bioavailable curcumin, quercitin out of Japan

Thera Innovations, a Canadian importer of dietary supplement ingreidients, has anounced a new supply deal for more bioavailable forms of curcumin and quercitin. The ingredients, branded as Theracumin and EMIQ, and are souced from Theravalues Corporation, a Japanese supplier.

HiActives powdered broccoli sprouts maintain nutritional potency: Futureceuticals

Futureceuticals says its HiActives broccoli sprout powder fills the void for a highly functional functional food and supplement ingredient, as the firm’s proprietary sprouting process and gentle-drying method creates a whole sprout powder (not an extract) that is “standardized to a higher level”.

science short

Chilli pepper capsaicin may inhibit gut tumours & extend mice lifespan by 30%: Research

Dietary capsaicin – the active ingredient found in chilli peppers – may trigger a reaction that reduces the risk of colorectal tumours, according to Californian research on mice.

DSM reads 'fini' in green tea and leaves it to Japanese

Dutch-Swiss ingredients giant DSM Nutritional Products (DNP) has called ‘time’ on Teavigo, a decade after launching the proprietary, weight management-focused green tea extract.

Despite extensive cancer claims, Noni fruit purveyor receives only warning letter from FDA

Puna Noni, a Hawaiian company marketing juice of the tropical Noni fruit, has received a warning letter from the Food and Drug Administration citing numerous violations, including cancer treatment claims and GMP failures. Considering the exhaustive list of transgressions in the letter, at least one observer questioned why FDA didn’t take the next step to file an injuction against the company.

‘Reassuring’: Harvard’s large-scale randomized trial in men supports safety of vitamin C and E supplements

Long-term use of vitamin C and E supplements do not increase the risk of cancer, while vitamin C may offer some colorectal benefits, according to a new analysis from Harvard researchers.

Mitochondria & aging: ‘Remarkable’ effects for nicotinamide riboside in mice, says new study

The science to support the potential benefits of nicotinamide riboside for age-related conditions continues to grow, with a new study from Europe indicating the compound may boost the number and size of mitochondria.

Lift of German kava ban, detailed in ABC article, expected to boost botanical in US market

An article published this week by the American Botanical Council lays out the story underlying a German court’s recent decision to lift a ban on kava, including the ways in which the legal goalposts moved around during the process.  Kava’s reinstatement, though it pertains only to the German market, is viewed a big development by an influential American observer.

FDA exemption speeds release of Plandai’s catechin supplement

Plandai Biotechnology Inc. will not be required to apply to the US Food and Drug Administration for New Dietary Ingredient status in order to market and sell its Phytofare Catechin Complex as a dietary supplement, enabling the firm to start marketing the supplement in the imminent third quarter.

Better together: Polyphenol may have greater bioavailability in combo with others

The amount of polyphenols absorbed and used by the body may be greater when taken with other polyphenols, according to a research review of the antioxidants.

IND guidance unfairly restricts supplement research, VDF FutureCeuticals says

The Food and Drug Administration has overstepped its bounds by ruling that a study’s endpoints, rather than the intended use of the product or ingredient being studies, determines whether an Investigational New Drug application must be filed in the opinion of VDF Futureceuticals, a dietary supplement ingredient supplier.

Policing social media made easier with new tool from Ingredient Identity

Consulting firm Ingredient Identity is offering a way to help companies manage their social media platforms to avoid crossing regulatory boundaries.  The new subscription service can help flag posts that make disease claims that could bring unwanted attention from the Food and Drug Administration.

Herbal industry increasingly backed by data, Rainbow Light's new science director says

The transformation of Rainbow Light mirrors that of the herbal industry as a whole, the company's new director of integrative science says.  Christopher Hobbs, a fairly newly-minted PhD, has worked with the firm as a formulator from the beginning as the company increasingly put its products on a solid science footing.

Nutrition researchers shoot holes in assertion that multivitamins are unnecessary

A response published today in the Annals of Internal Medicine by four well-known nutrition researchers takes strident issue with an editorial published in the same journal that multivitamins are not useful.  The authors of the first paper “ignored decades of nutrition research and diet monitoring of the U.S. population to reach this misleading conclusion,” the researchers wrote.

Related News

Key Industry Events

Product Innovation